Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Ferry Sandra

First Department of Oral and Maxillofacial Surgery

Faculty of Dentistry

Kyushu University

3-1-1 Maidashi

Japan

Name/email consistency: high

First Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Kyushu University, 3-1-1 Maidashi, Japan. 2001 - 2006

Inhibition of Akt and MAPK pathways elevated potential of TNFalpha in inducing apoptosis in ameloblastoma. Sandra, F., Hendarmin, L., Nakao, Y., Nakamura, N., Nakamura, S. Oral Oncol. (2006) [Pubmed]
Ameloblastoma induces osteoclastogenesis: a possible role of ameloblastoma in expanding in the bone. Sandra, F., Hendarmin, L., Kukita, T., Nakao, Y., Nakamura, N., Nakamura, S. Oral Oncol. (2005) [Pubmed]
TRAIL cleaves caspase-8, -9 and -3 of AM-1 cells: a possible pathway for TRAIL to induce apoptosis in ameloblastoma. Sandra, F., Hendarmin, L., Nakao, Y., Nakamura, N., Nakamura, S. Tumour Biol. (2005) [Pubmed]
Midkine induced growth of ameloblastoma through MAPK and Akt pathways. Sandra, F., Harada, H., Nakamura, N., Ohishi, M. Oral Oncol. (2004) [Pubmed]
Immunohistochemical evaluation of PCNA and Ki-67 in ameloblastoma. Sandra, F., Mitsuyasu, T., Nakamura, N., Shiratsuchi, Y., Ohishi, M. Oral Oncol. (2001) [Pubmed]
Two relatively distinct patterns of ameloblastoma: an anti-apoptotic proliferating site in the outer layer (periphery) and a pro-apoptotic differentiating site in the inner layer (centre). Sandra, F., Nakamura, N., Mitsuyasu, T., Shiratsuchi, Y., Ohishi, M. Histopathology (2001) [Pubmed]